Hamid Mirshahidi
0000-0002-7911-7118
1 paper found
Refreshing results…
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)
Missing publications? Search for publications with a matching author name.